LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT.OB) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 12 transactions totaling $1.3M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Dec 7, 2018 involved a purchase of 1,260,000 shares valued at $630.0K.
No significant insider buying has been recorded for LIXT.OB in the recent period.
No significant insider selling has been recorded for LIXT.OB in the recent period.
Based on recent SEC filings, insider sentiment for LIXT.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading LIXT.OB stock, having executed 12 transactions in the past 90 days. The most active insider is Arthur Riggs (Executive), who has made 1 transactions totaling $630.0K.
Get notified when executives and directors at LIXT.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 7, 2018 | Riggs Arthur | Executive | Purchase | 1,260,000 | $0.50 | $630.0K | Large |
| Dec 7, 2018 | J. Forman Stephen | Executive | Purchase | 100,000 | $0.50 | $50.0K | |
| Dec 7, 2018 | F. Palmedo Philip | Executive | Purchase | 100,000 | $0.50 | $50.0K | |
| Dec 7, 2018 | Schwartzberg Gil | Executive | Gift | 600,000 | $N/A | $0 | |
| Dec 7, 2018 | Schwartzberg Gil | Executive | Purchase | 1,040,000 | $0.50 | $520.0K | Large |
| Dec 7, 2018 | Schwartzberg Gil | Executive | Other | 150,000 | $N/A | $0 | |
| Feb 19, 2016 | Forman Eric | Executive | Purchase | 10,000 | $0.30 | $3.0K | |
| Feb 17, 2016 | Forman Eric | Executive | Purchase | 43,500 | $0.30 | $13.1K | |
| Feb 4, 2016 | Forman Eric | Executive | Gift | 34,000 | $N/A | $0 | |
| Feb 4, 2016 | Forman Eric | Executive | Purchase | 2,500 | $0.25 | $625 | |
| Aug 4, 2015 | S. Kovach John | Executive | Gift | 8,000,000 | $N/A | $0 | |
| Mar 17, 2015 | S. Kovach John | Executive | Other | 92,717 | $1.00 | $92.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $1.3M | 93.2% |
Other(J) | 2 | $92.7K | 6.8% |
Gift(G) | 3 | $0 | 0.0% |
Insiders at LIXTE BIOTECHNOLOGY HOLDINGS, INC. are accumulating shares at an accelerated pace. With 6 insiders making 12 transactions totaling $1.3M in purchases versus $0 in sales, the net buying activity of $1.3M signals strong executive confidence. Arthur Riggs (Executive) leads the buying activity with $630.0K in transactions across all time.